Az To File Triple Combination Therapy For Copd | Latest News RSS feed

Az To File Triple Combination Therapy For Copd - Latest News


AZ to file triple combination therapy for COPD

Global Medicines at AZ, said: “We are encouraged by the results of the KRONOS trial which demonstrate PT010’s efficacy in improving lung function and its potential value as a triple combination therap... read more

Glaxo accelerates regulatory plan for triple combo therapy for COPD; NDA filing expected by year end

Buoyed by discussions with the FDA, GlaxoSmithKline (NYSE:GSK) plans to file its New Drug Application (NDA) seeking approval of its triple combination therapy for the treatment of chronic obstructive ... read more

GSK Files Regulatory Submission in European Union for Once-Daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD

--(BUSINESS WIRE)--GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced the filing ... a maintenance treatment to relieve symptoms of adult patients with COPD. It is b... read more

Looking for another news?


AZ boosted by COPD triple inhaler results

AZ’s single inhaler, PT010, showed statistically significant improvement in eight of nine lung ... and could file in the US and Europe next year. GlaxoSmithKline’s Trelegy is approved in the EU and US ... read more


GSK files first application for triple COPD therapy

GlaxoSmithKline has submitted its three-in-one treatment for chronic obstructive pulmonary disease (COPD) in the US, more than a year earlier than planned. GSK had previously suggested it would file t... read more

AZ Reports Phase III Results for PT010 in COPD

... to play an increasingly important role in addressing the needs of the many COPD patients who are currently undertreated or are receiving triple combination therapy as separate medicines in multipl... read more

Glaxo/Innoviva File for Approval of Trelegy Ellipta in Japan

The therapy ... photos The filing included data from the Phase III IMPACT study, evaluating the safety and effectiveness of Trelegy Ellipta in comparison to existing COPD therapies. The study revealed ... read more

Immunomedics Announces Publication of Triple-Negative Breast Cancer Data With Sacituzumab Govitecan in the New England Journal of Medicine

"Patients with mTNBC have an aggressive tumor biology, and effective treatment options for ... non-small cell lung, and other hard-to-treat solid tumor indications, as monotherapy or in combination wi... read more

Patients With COPD May Soon Benefit From the Chiesi Farmaceutici's Investigation Into a Fixed Triple Combination ICS/LABA/LAMA

"These studies show a consistent effect of the fixed triple therapy combination on a range of outcomes ... we are on track with the plan that foresees the filing [in the EU] by IV quarter of the curre... read more

AZ’ triple combo COPD inhaler hits PhIII targets

AstraZeneca recently unveiled top-line trial data backing use of an experimental triple combination therapy being ... characterise the role of this potential treatment for patients with COPD,” said AZ ... read more

How Will GlaxoSmithKline's Triple Therapy Combination Perform In The Market?

Potential Market Opportunity 18 percent of the COPD patients on treatment ... How much market share can GSK's triple therapy combination get ? GSK's closed triple therapy combination is expected to be ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us